Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission

Diabetes Research and Clinical Practice

Volumn 108, Issue 2, 2015, Pages 250-257

  Liu, Liehua ^a   Ke, Weijian ^a   Wan, Xuesi ^a   Zhang, Pengyuan ^a   Cao, Xiaopei ^a   Deng, Wanping ^a   Li, Yanbing ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Insulin requirement; Intensive insulin therapy; Newly diagnosed type 2 diabetes; Remission

Indexed keywords

GLUCOSE; INSULIN ASPART; INSULIN LISPRO; LIPID; TRIACYLGLYCEROL; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; ARTICLE; BODY WEIGHT; CELL FUNCTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; RELAPSE; REMISSION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SHORT COURSE THERAPY; WAIST CIRCUMFERENCE; AGED; BLOOD; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION; DRUG EFFECTS; INSULIN INFUSION; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; LIPIDS; MALE; MIDDLE AGED; REMISSION INDUCTION;

EID: 84927912296     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2015.02.011     Document Type: Article

References (30)

1. Xu Y., Wang L., He J., Bi Y., Li M., Wang T., et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013, 310:948-959.
2. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998, 352:854-865.
3. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., Neil H.A. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359:1577-1589.
4. Kahn S.E., Haffner S.M., Heise M.A., Herman W.H., Holman R.R., Jones N.P., et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006, 355:2427-2443.
5. Li Y., Xu W., Liao Z., Yao B., Chen X., Huang Z., et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care 2004, 27:2597-2602.
6. Son J.W., Jeong H.K., Lee S.S., Kim S.R., Cha B.Y., Son H.Y., et al. The Effect of early intensive insulin therapy on body fat distribution and beta-cell function in newly diagnosed type 2 diabetes. Endocr Res 2013, 38:160-167.
7. Weng J., Li Y., Xu W., Shi L., Zhang Q., Zhu D., et al. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet 2008, 371:1753-1760.
8. Hu Y., Li L., Xu Y., Yu T., Tong G., Huang H., et al. Short-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and beta-cell function in subjects with long-term remission. Diabetes Care 2011, 34:1848-1853.
9. Kramer C.K., Zinman B., Retnakaran R. Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2013, 1:28-34.
10. Chinese guidline for type 2 diabetes-2013. Chin J Diabetes Mellitus 2014; 6:447-498, . doi:10.3760/cma.j.issn.1674-5809.2014.07.004.
11. Liu J., Liu J., Fang D., Liu L., Huang Z., Wan X., et al. Fasting plasma glucose after intensive insulin therapy predicted long-term glycemic control in newly diagnosed type 2 diabetic patients. Endocr J 2013, 60:725-732.
12. Liu L., Wan X., Liu J., Huang Z., Cao X., Li Y. Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy. Diabetes Technol Ther 2012, 14:756-761.
13. Xu W., Li Y.B., Deng W.P., Hao Y.T., Weng J.P. Remission of hyperglycemia following intensive insulin therapy in newly diagnosed type 2 diabetic patients: a long-term follow-up study. Chin Med J (Engl) 2009, 122:2554-2559.
14. Huang Z., Wan X., Liu J., Deng W., Chen A., Liu L., et al. Short-term continuous subcutaneous insulin infusion combined with insulin sensitizers rosiglitazone, metformin, or antioxidant alpha-lipoic acid in patients with newly diagnosed type 2 diabetes mellitus. Diabetes Technol Ther 2013, 15:859-869.
15. WHO Definition, diagnosis and classifications of diabetes mellitus and its complications. Report of a WHO consultation, Part 1: Diagnosis and classification of diabetes mellitus 1999.
16. Noh Y.H., Lee W.J., Kim K.A., Lim I., Lee J.H., Lee J.H., et al. Insulin requirement profiles of patients with type 2 diabetes after achieving stabilized glycemic control with short-term continuous subcutaneous insulin infusion. Diabetes Technol Ther 2010, 12:271-281.
17. Gao G.Q., Dong Q.Y., Li S.J., Zhang Y.Y., Li W.X., Du W.H., et al. Investigation of the insulin dose and characteristics of continuous subcutaneous insulin infusion in Chinese people with type 2 diabetes. Diabetes Technol Ther 2011, 13:1135-1138.
18. Cai X., Han X., Luo Y., Ji L. Analysis of insulin doses of Chinese type 2 diabetic patients with intensive insulin treatment. PLoS ONE 2012, 7:e38962.
19. Kuroda A., Kaneto H., Yasuda T., Matsuhisa M., Miyashita K., Fujiki N., et al. Basal insulin requirement is ~30% of the total daily insulin dose in type 1 diabetic patients who use the insulin pump. Diabetes Care 2011, 34:1089-1090.
20. Yang W., Liu J., Shan Z., Tian H., Zhou Z., Ji Q., et al. Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial. Lancet Diabetes Endocrinol 2014, 2:46-55.
21. Papa G., Baratta R., Cali V., Degano C., Iurato M.P., Licciardello C., et al. Factors that influence basal insulin requirement in type 2 diabetes. Acta Diabetol 2012, 49:387-393.
22. Wittlin S.D. Treating the spectrum of type 2 diabetes: emphasis on insulin pump therapy. Diabetes Educ 2006, 32:39S-46S.
23. Nathan D.M., Buse J.B., Davidson M.B., Ferrannini E., Holman R.R., Sherwin R., et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009, 32:193-203.
24. Chibalin A.V., Leng Y., Vieira E., Krook A., Bjornholm M., Long Y.C., et al. Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance. Cell 2008, 132:375-386.
25. Tang S., Le-Tien H., Goldstein B.J., Shin P., Lai R., Fantus I.G. Decreased in situ insulin receptor dephosphorylation in hyperglycemia-induced insulin resistance in rat adipocytes. Diabetes 2001, 50:83-90.
26. Kim M.K., Jang E.H., Son J.W., Kwon H.S., Baek K.H., Lee K.W., et al. Visceral obesity is a better predictor than generalized obesity for basal insulin requirement at the initiation of insulin therapy in patients with type 2 diabetes. Diabetes Res Clin Pract 2011, 93:174-178.
27. Biesenbach G., Raml A., Alsaraji N. Weight gain and insulin requirement in type 2 diabetic patients during the first year after initiating insulin therapy dependent on baseline BMI. Diabetes Obes Metab 2006, 8:669-673.
28. Chen A., Huang Z., Wan X., Deng W., Wu J., Li L., et al. Attitudes toward diabetes affect maintenance of drug-free remission in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion treatment. Diabetes Care 2012, 35:474-481.
29. Bhattacharya S., Ammini A.C., Jyotsna V., Gupta N., Dwivedi S. Recovery of beta-cell functions with low-dose insulin therapy: study in newly diagnosed type 2 diabetes mellitus patients. Diabetes Technol Ther 2011, 13:461-465.
30. Harrison L.B., Adams-Huet B., Li X., Raskin P., Lingvay I. Intensive therapy in newly diagnosed type 2 diabetes: results of a 6-year randomized trial. J Investig Med 2014, 62:676-686.